Improving tic control in youth with chronic tic disorders
Official title: Modeling Tic Change During Behavior Therapy for Tics
Run by University of Minnesota · NCT06270251 · Data updated 2026-11-12
This study is testing whether a new therapy can help young people aged 12-21 manage their tics better and improve their daily life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 21 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | March 1, 2028 |
| Study ends | September 1, 2028 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT06270251 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are youth aged 12-21 with chronic motor and/or vocal tics of moderate severity.
✕Probably not a fit
Patients with active suicidality, psychosis, or those currently undergoing psychotherapy for tics may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on the effectiveness of Comprehensive Behavioral Intervention for Tics (CBIT) in treating chronic tic disorders in youth aged 12-21. Participants will learn to manage their tics through competing response training, which involves applying alternative motor actions to inhibit tics. The study aims to evaluate the impact of this behavioral therapy on tic severity and overall functioning. By assessing the outcomes, the research seeks to enhance the understanding of tic management in this population.
Why it matters
Potential benefit: If successful, this intervention could significantly improve tic control and quality of life for patients with chronic tic disorders.
How similar studies have gone: Previous studies have shown that CBIT is effective in reducing tic severity, indicating a promising approach for this intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 12-21 years at time of enrollment. * Current chronic motor and/or vocal tics, defined as tics for at least 1 year without a tic-free period of more than 3 consecutive months. Tics must not be due to a medical condition or the direct physiological effects of a substance. * At least moderate tic severity, defined as a Yale Global Tic Severity Scale total score ≥14 (≥9 for those with motor or vocal tics only). * Full scale IQ greater than 70 * English fluency to ensure comprehension of study measures and instructions. Exclusion Criteria: * Active suicidality. * Previous diagnosis of psychosis or cognitive disability. * Substance abuse or dependence within the past year. * Concurrent psychotherapy focused on tics. * Neuroleptic/antipsychotic medications. * Taking a medication that has not reached stability criterion (same medication and dose for 6 weeks with no planned changes over the intervention period)
Where it's running
-
University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Christine Conelea, PhD — University of Minnesota
- Study coordinator: Brianna Wellen, PhD
- Phone: 6126265472
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Internet-based behavior therapy for adults with Tourette syndrome
This study is testing whether an online behavior therapy can help adults with Tourette syndrome reduce their tics and improve their overall well-being compared to general support.
-
Breath test to tell if a child has a viral respiratory infection vs. a healthy kid
This pilot test checks whether the MBP Breath Analyzer can detect distinct breath signatures in kids with acute respiratory infection compared to healthy peers.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Bayesian optimization to tune DBS for better gait in Parkinson’s patients
This study tests whether using Bayesian optimization can quickly find DBS settings that lengthen step length in people with Parkinson's who already have DBS in place.
-
State Representation in Early Psychosis 2
This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.
-
Maintenance radiotherapy after standard glioblastoma treatment
This study tests whether a single 2 Gy maintenance radiotherapy dose after standard treatment is safe and feasible for adults with newly diagnosed glioblastoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.